Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Kidd

Showing results (71-80 of 162) with videos related to

Pageof 17
Sort By:
World Journal of Surgical Oncology|May 26, 2010
Differentiating the impact of anatomic and non-anatomic liver resection on early recurrence in patients with Hepatocellular CarcinomaKarim M Eltawil, Mark Kidd, Francesco Giovinazzo, et al.
Cancer|March 10, 2011
Limitations in small intestinal neuroendocrine tumor therapy by mTor kinase inhibition reflect growth factor-mediated PI3K feedback loop activation via ERK1/2 and AKTBernhard Svejda, Mark Kidd, Alexander Kazberouk, et al.
Medical Molecular Morphology|June 22, 2012
Ultrastructure of ECL cells in Mastomys after long-term treatment with H2 receptor antagonist loxtidineReidar Alexander Vigen, Mark Kidd, Irvin M Modlin, et al.
Gastroenterology|May 12, 2005
Current status of gastrointestinal carcinoidsIrvin M Modlin, Mark Kidd, Igor Latich, et al.
Cancer|May 14, 2008
Bronchopulmonary neuroendocrine tumorsBjorn I Gustafsson, Mark Kidd, Anthony Chan, et al.
The Prostate|January 22, 2025
Clinical Sensitivity and Specificity of the PROSTest in an American CohortKambiz Rahbar, Mark Kidd, Vikas Prasad, et al.
Cancer Epidemiology|August 9, 2024
Evaluation of a multigenomic liquid biopsy (PROSTest) for prostate cancer detection and follow-up in a Caribbean populationR David Rosin, Amelia Haynes, Mark Kidd, et al.
Cancer|January 29, 2008
Inhibition of proliferation of small intestinal and bronchopulmonary neuroendocrine cell lines by using peptide analogs targeting receptorsMark Kidd, Andrew V Schally, Roswitha Pfragner, et al.
Neuroendocrinology|April 15, 2016
NET Blood Transcript Analysis Defines the Crossing of the Clinical Rubicon: When Stable Disease Becomes ProgressiveMarianne Pavel, Henning Jann, Vikas Prasad, et al.
Seminars in Nuclear Medicine|April 13, 2016
Radiolabeled Somatostatin Analogue Therapy Of Gastroenteropancreatic CancerLisa Bodei, Dik J Kwekkeboom, Mark Kidd, et al.
Pageof 17

Showing results (71-80 of 162) with videos related to

Sort By:
Pageof 17
World Journal of Surgical Oncology|May 26, 2010
Differentiating the impact of anatomic and non-anatomic liver resection on early recurrence in patients with Hepatocellular CarcinomaKarim M Eltawil, Mark Kidd, Francesco Giovinazzo, et al.
Cancer|March 10, 2011
Limitations in small intestinal neuroendocrine tumor therapy by mTor kinase inhibition reflect growth factor-mediated PI3K feedback loop activation via ERK1/2 and AKTBernhard Svejda, Mark Kidd, Alexander Kazberouk, et al.
Medical Molecular Morphology|June 22, 2012
Ultrastructure of ECL cells in Mastomys after long-term treatment with H2 receptor antagonist loxtidineReidar Alexander Vigen, Mark Kidd, Irvin M Modlin, et al.
Gastroenterology|May 12, 2005
Current status of gastrointestinal carcinoidsIrvin M Modlin, Mark Kidd, Igor Latich, et al.
Cancer|May 14, 2008
Bronchopulmonary neuroendocrine tumorsBjorn I Gustafsson, Mark Kidd, Anthony Chan, et al.
The Prostate|January 22, 2025
Clinical Sensitivity and Specificity of the PROSTest in an American CohortKambiz Rahbar, Mark Kidd, Vikas Prasad, et al.
Cancer Epidemiology|August 9, 2024
Evaluation of a multigenomic liquid biopsy (PROSTest) for prostate cancer detection and follow-up in a Caribbean populationR David Rosin, Amelia Haynes, Mark Kidd, et al.
Cancer|January 29, 2008
Inhibition of proliferation of small intestinal and bronchopulmonary neuroendocrine cell lines by using peptide analogs targeting receptorsMark Kidd, Andrew V Schally, Roswitha Pfragner, et al.
Neuroendocrinology|April 15, 2016
NET Blood Transcript Analysis Defines the Crossing of the Clinical Rubicon: When Stable Disease Becomes ProgressiveMarianne Pavel, Henning Jann, Vikas Prasad, et al.
Seminars in Nuclear Medicine|April 13, 2016
Radiolabeled Somatostatin Analogue Therapy Of Gastroenteropancreatic CancerLisa Bodei, Dik J Kwekkeboom, Mark Kidd, et al.
Pageof 17